EUROSCARF
Johann Wolfgang Goethe-Universität Frankfurt	Tel.: +49-69-798-29533
Institut für Molekulare Biowissenschaften	Fax.: +49-69-798-29527
Max-von-Laue-Str. 9; Geb.: N250	Email: Euroscarf@em.uni-frankfurt.de
D-60438 Frankfurt / M.	http://www.uni-frankfurt.de
Germany	/fb15/mikro/euroscarf/index.html

Material Transfer Agreement

Details of Principal Investigator requesting the Strains ("RECIPIENT"):

Name (Principal Investigator)

Institution

Department

Address

Postal Zip Code

City

Country

email-address

Strains:

EUROSCARF accession numbers

Please complete the document by computer or typewriter.

Please sign the agreement and have it signed/stamped by a representative of your institution authorized to sign this agreement and send the original to EUROSCARF.

Please do not fax this agreement

The strains you are inquiring are constructed by CellZome AG (Heidelberg, Germany) and are covered by a European patent application.

The terms for ordering the strains are stated below and can also be found on http://yeast.cellzome.com/MTA/MTA.html

This sheet, or the information given in the sheet, will be communicated to CellZome.

Terms:

1. "Strain" will mean all material provided by EUROSCARF including any derivatives and any offspring.

2. The STRAINS may only be used in the field of protein complex purification.

3. The STRAINS will only be used for research purposes and for no commercial purpose whatsoever

4. The RECIPIENT will not manufacture, sell or sublicence for manufacture and sale upon commercial basis the STRAINS. The STRAINS will be used in accordance with applicable laws and regulations. The STRAINS will not be used in humans. Any other use or exploitation of the STRAINS requires the prior consent of CELLZOME.

5. Nothing in this agreement shall be construed as granting any license under any intellectual property right.

6. The RECIPIENT and any research assistant, co-workers or other workers who may use STRAINS agree not to transfer the STRAINS to a third party.

7. The RECIPIENT will inform CELLZOME about results of the research using the STRAINS at least 60 days prior to publication. In any publication resulting from the research on the STRAINS, the RECIPIENT will properly cite CELLZOME´s contribution. If the RECIPIENT´s research involving the STRAINS results in an invention which may be commercially valuable, RECIPIENT hereby grants to CELLZOME the first option to an exclusive license at a reasonable royalty to be negotiated in good faith between the RECIPIENT/INSTITUTION and CELLZOME to commercially use the invention or substance under terms that are commercially reasonable. CELLZOME agrees to keep these results confidential. The obligation for confidentiality shall not extend to any information which is available to the public, is already known or subsequently disclosed by third parties to the recipient party and at its free disposal.

8. CELLZOME and EUROSCARF do not assume any responsibility for the STRAINS and the use of the STRAINS. CELLZOME and EUROSCARF do not assume any liability for damages occurring through the use of the STRAINS and do not guarantee the suitability of the STRAINS for any applications. The RECIPIENT will hold CELLZOME and EUROSCARF harmless for any claims on damages which occur during the RECIPIENT´S use of the STRAINS: CELLZOME and EUROSCARF do not warrant for any possible infringement of rights.

9. This agreement may be terminated by CELLZOME after a material breach of the agreement by the RECIPIENT. RECIPIENT will return the STRAINS and their modifications to CELLZOME.

10. If any one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby.

ACCEPTED AND AGREED

PRINCIPAL INVESTIGATOR UNIVERSITY / INSTITUTION

Signature: _____________________ Signature: _____________________
Authorized Representative

Name: ________________________ Name: ________________________
Authorized Representative

Title:__________________________ Title: _________________________

Stamp: ________________________

Date: _____________ Date: _____________

Name (Principal Investigator)
Institution
Department
Address
Postal Zip Code
City
Country
email-address

PRINCIPAL INVESTIGATOR	UNIVERSITY / INSTITUTION
Signature: _____________________	Signature: _____________________ Authorized Representative
Name: ________________________	Name: ________________________ Authorized Representative
Title:__________________________	Title: _________________________

	Stamp: ________________________
Date: _____________	Date: _____________